4.45
-0.04 (-0.89%)
Penutupan Terdahulu | 4.49 |
Buka | 4.47 |
Jumlah Dagangan | 764,354 |
Purata Dagangan (3B) | 1,481,218 |
Modal Pasaran | 1,707,064,320 |
Harga / Pendapatan (P/E TTM) | 111.25 |
Harga / Pendapatan (P/E Ke hadapan) | 10.45 |
Harga / Jualan (P/S) | 2.22 |
Harga / Buku (P/B) | 2.37 |
Julat 52 Minggu | |
Tarikh Pendapatan | 7 May 2025 |
Margin Keuntungan | 2.07% |
Margin Operasi (TTM) | 19.41% |
EPS Cair (TTM) | 0.040 |
Pertumbuhan Hasil Suku Tahunan (YOY) | 1.00% |
Pertumbuhan Pendapatan Suku Tahunan (YOY) | -88.60% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 74.99% |
Nisbah Semasa (MRQ) | 5.32 |
Aliran Tunai Operasi (OCF TTM) | 183.89 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | 116.77 M |
Pulangan Atas Aset (ROA TTM) | 3.62% |
Pulangan Atas Ekuiti (ROE TTM) | 2.20% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Health Information Services (US) | Menurun | Bercampur |
Health Information Services (Global) | Menurun | Bercampur | |
Stok | GoodRx Holdings, Inc. | Bercampur | Menurun |
AISkor Stockmoo
Konsensus Penganalisis | 1.0 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | 0.5 |
Purata Bergerak Teknikal | 1.0 |
Osilator Teknikal | 2.0 |
Purata | 1.13 |
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services. |
|
Sektor | Healthcare |
Industri | Health Information Services |
Gaya Pelaburan | Small Core |
% Dimiliki oleh Orang Dalam | 11.56% |
% Dimiliki oleh Institusi | 63.27% |
Pemilikan
Nama | Tarikh | Syer Dipegang |
---|---|---|
Petrus Trust Company, Lta | 31 Dec 2024 | 2,950,089 |
Rip Road Capital Partners Lp | 31 Dec 2024 | 2,408,577 |
Technology Crossover Management X, Ltd. | 31 Dec 2024 | 1,653,566 |
Julat 52 Minggu | ||
Julat Harga Sasaran | ||
Tinggi | 7.00 (Wells Fargo, 57.30%) | Beli |
Median | 6.25 (40.45%) | |
Rendah | 5.50 (Truist Securities, 23.60%) | Pegang |
Purata | 6.25 (40.45%) | |
Jumlah | 1 Beli, 1 Pegang | |
Harga Purata @ Panggilan | 4.48 |
Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
---|---|---|---|---|
Wells Fargo | 29 Apr 2025 | 7.00 (57.30%) | Beli | 4.63 |
28 Feb 2025 | 8.00 (79.78%) | Beli | 4.98 | |
Truist Securities | 10 Apr 2025 | 5.50 (23.60%) | Pegang | 4.32 |
Tiada data dalam julat masa ini.
Tarikh | Jenis | Butiran |
---|---|---|
09 Apr 2025 | Pengumuman | GoodRx Announces Date for First Quarter 2025 Earnings Release and Conference Call |
03 Apr 2025 | Pengumuman | GoodRx Introduces New E-commerce Experience for Retail Pharmacies |
17 Mar 2025 | Pengumuman | GoodRx Appoints Aaron Crittenden as President of Rx Marketplace and Scott Pope, PharmD, as Chief Pharmacy Officer and Head of Clinical Engagement |
10 Mar 2025 | Pengumuman | GoodRx Report Reveals Striking Gender Divide in Prescription Medication Spending |
27 Feb 2025 | Pengumuman | GoodRx Reports Fourth Quarter and Full Year 2024 Results |
18 Feb 2025 | Pengumuman | GoodRx Achieves HITRUST i1 Certification to Manage Data Protection and Mitigate Cybersecurity Threats |
05 Feb 2025 | Pengumuman | GoodRx Appoints Christopher A. McGinnis as Chief Financial Officer |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |